We partner with 503B compounding pharmacies across The United States to provide you with the highest-quality compounded solutions for IM and IV administration. We have listed just a few of the many things they offer, see below!
Outsourcing facilities are sometimes referred to as 503B facilities because 503B refers to the filling of “office use” or “office administered” medications. The FDA created this new designation of compounding pharmacy to establish a new level of patient care, safety, and guidelines. Outsourcing facilities must comply with strict cGMP (current good manufacturing practices) which are the same standards and guidelines that pharmaceutical manufacturers follow. The outsourcing facilities are now the ONLY pharmacies permitted, under the new law, to provide compounded medications for use in physicians’ offices, clinics, and hospitals.